查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1146205

低温恆温器微生物组设备市场 - 增长、趋势、COVID-19 影响和预测（2022-2027 年）

Cryostat Microbiome Equipment Market - Growth, Trends, and Forecasts (2022 - 2027)
出版日期: | 出版商: Mordor Intelligence | 英文 89 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计低温恆温器微生物组设备市场在预测期间（2022-2027 年）的复合年增长率为 6.89%。

由于 COVID-19 大流行，医疗保健系统面临巨大挑战。在 COVID-19 大流行期间，大多数慢性护理被认为是不紧急的，因此所有门诊护理都被推迟或限制，以降低病毒传播的风险。低温恆温器微生物组仪器广泛用于组织病理学研究的诊断和实验室。 COVID-19 对癌症等慢性疾病的研究产生了严重影响。一篇题为“COVID-19 大流行对癌症研究人员的影响”的论文。 2021 年 11 月发表在公共卫生前沿的事件定性研究为缓解策略提供资讯，讨论了 COVID-19 大流行对癌症研究人员的影响。在本文中，癌症研究数量下降的主要限制是资金、患者获得研究的机会有限、患者获得癌症护理的机会减少、人员配备问题、行政延误或供应不足。引用了各种因素，包括连锁问题。处理此类低温恆温器微生物组设备的训练有素的人员短缺和供应链中断预计将对市场增长产生重大影响。

然而，对 COVID-19 感染组织的免疫组织化学研究的增加，以及日益严重的流行病，正在对低温恆温器微生物组设备市场的增长产生积极影响。例如，2021 年 9 月发表在 Elsevier Immunology 上的论文“小鼠 SARS-CoV-2 感染的实时成像”揭示了中和抗体需要 Fc 功能才能使中和抗体在治疗 COVID-19 中发挥最佳功效。我们研究了疗效和实施器官冷冻免疫组织学进一步研究。预计低温恆温器微生物组设备的这种越来越多的使用将在预测期内促进市场增长。

癌症、心血管疾病、慢性肺病、中风、阿尔茨海默病、糖尿病和慢性肾病等主要慢性疾病在全球范围内呈上升趋势，推动了低温恆温器微生物组设备市场的增长。我在打电话。癌症是全球死亡的主要原因，预计到 2020 年将导致大约 1000 万人死亡。根据 GLOBOCAN 2020 报告，据说 2020 年全球癌症患者总数约为 19,292,789 人。预计到 2040 年将增加到 28,887,940 人。根据国际糖尿病联盟的《2021 年第十版糖尿病地图集》，2021 年全球将有约 5.37 亿成年人被诊断患有糖尿病，到 2030 年这一数字将上升到 6.43 亿，预计到 2045 年将增加到 7.83 亿。受慢性疾病影响的大量人口以及对低温恆温器微生物组设备的需求增加以促进此类疾病的诊断和治疗预计将推动低温恆温器微生物组设备市场的增长。

因此，预计上述因素将在预测期内推动市场增长。

主要市场趋势

在低温恆温器微生物组设备市场，诊断和研究实验室部分预计将占据主要市场份额。

诊断和研究实验室占低温恆温器微生物组设备市场的主要部分。低温恆温器微生物组仪器在活组织检查等组织的免疫组织化学和组织病理学研究中发挥着重要作用。在 2020 年 12 月发表在《美国国家科学院院刊》上的题为“Deep learning extended depth-of-field microscope for fast and slide-free histology”的论文中，低温恆温器微生物组在很短的处理时间内切割出薄薄的组织切片. 它已被证明是一种广泛使用的方法

此外，2021 年 8 月发表在 Journal of Visualized Experiments 上的题为“Histological-Based Stainings using Free-Floating Tissue Sections”的文章讨论了自由流动法在荧光免疫化学染色中的应用。本文表明，低温恆温器微生物组装置是许多研究人员切片和收穫组织的首选方法。本研究旨在减少对切片冷冻组织进行染色的处理时间。此类研究调查的增加使低温恆温器微生物组设备易于使用，预计将在预测期内推动低温恆温器微生物组设备市场的增长。

需要使用低温恆温器微生物组设备来诊断感染组织的癌症病例和相关治疗的增加可能会推动市场增长。例如，2021 年 2 月在 Dermatologic Surgery 上发表的题为“Diagnostic Biopsy via In-Office Frozen Sections for Clinical Nonmelanoma Skin Cancer”的论文报导了临床非黑色素瘤皮肤癌冰冻切片活检的准确性和准确性。 .结果表明，通过冰冻切片进行的院内活检可以帮助更准确地识别非黑色素瘤皮肤癌细胞并加快诊断和治疗，从而提高结果和患者满意度。使用低温恆温器微生物组设备诊断和治疗癌症病例的研究增加预计将在预测期内促进研究市场的增长。

北美将占市场的重要份额，预测期（2022-2027 年）也是如此。

预计在製造低温恆温器微生物组设备方面越来越多地采用先进技术和系统以及免疫组织化学研究方面的技术进步将推动北美地区的市场增长。公众对市场上创新低温恆温器微生物组仪器模型的高度认识有助于该地区市场的高速增长。

北美地区慢性病病例数量的增加正在推动低温恆温器微生物组设备市场的增长。癌症是美国十大死因之一。根据 GLOBOCAN 2020 报告，2020 年美国癌症总人数将占到大约 2,281,658 人。预计到 2040 年将增加到 3,123,452 人。根据国际糖尿病联盟的数据，到2021年，美国将有3221.53万成年人患有糖尿病，患病率超过13%。美国疾病控制和预防中心估计，到 2021 年，将有 3700 万美国成年人患有慢性肾病。美国疾病控制与预防中心 2020 年的一份报告显示，大约有 1570 万美国人患有慢性下呼吸道疾病。受慢性疾病影响的大量人口以及对低温恆温器微生物组设备的需求增加以促进此类疾病的诊断和治疗预计将推动低温恆温器微生物组设备市场的增长。

此外，预计美国医疗保健支出的增加将推动该地区对低温恆温器微生物组设备市场的需求。根据美国医疗保险和医疗补助服务中心的 2020 年国家卫生支出数据，2020 年的医疗支出增长高达 9.7%，达到 4.1 万亿美元，约占国内生产总值的 19.7%。预计到 2028 年将达到 6.2 万亿美元。在研究的预测期内，美国地区医疗保健支出的增加可能会促进低温恆温器微生物组设备市场的增长。

因此，众所周知，对低温恆温器微生物组设备的需求增加以及对医疗保健行业的投资增加会推动该地区的市场增长。

竞争格局

低温恆温器微生物组设备市场是一个分散的竞争，由几个大型参与者组成。就市场份额而言，少数主要参与者目前主导着市场。目前主导市场的公司包括 Amos Scientific Pty.Ltd.、Bright Instruments Ltd.、Cardinal Health、Epredia、Hacker Instruments &Industries Inc.、Histo-Line Laboratories S.R.L.、Kalstein France、 Labtron Equipment Ltd.、Leica Microsystems Nussloch GmbH、 Medimeas Instruments、 Sakura Finetek Usa Inc、Slee Medical Gmbh、 Spensers World、 Tanner Scientific Inc、Zhejiang Jinhua Kedi Instrumental Equipment等。

其他特典

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第 1 章介绍

  • 研究假设和市场定义
  • 本次调查的范围

第 2 章研究方法

第 3 章执行摘要

第 4 章市场动态

  • 市场概览
  • 市场促进因素
    • 慢性病患病率增加
    • 医疗保健支出增加
  • 市场抑制因素
    • 缺乏熟练的专业人员
  • 波特五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分

  • 按产品
    • 手动低温恆温器微生物组装置
    • 半自动低温恆温器型切片机
    • 自动切片机低温恆温器设备
  • 最终用户
    • 医院
    • 门诊手术中心
    • 诊断和研究机构
  • 按地区
    • 北美
    • 欧洲
    • 亚太地区
    • 中东和非洲
    • 南美洲

第 6 章竞争格局

  • 公司简介
    • Amos Scientific Pty. Ltd.
    • Bright Instruments Ltd.
    • Cardinal Health
    • Epredia
    • Hacker Instruments & Industries Inc.
    • Histo-Line Laboratories S.R.L.
    • Kalstein France
    • Labtron Equipment Ltd.
    • Leica Microsystems Nussloch GmbH
    • Medimeas Instruments
    • Sakura Finetek Usa Inc.
    • Slee Medical Gmbh
    • Spensers World
    • Tanner Scientific Inc.
    • Zhejiang Jinhua Kedi Instrumental Equipment Co., Ltd.

第 7 章市场机会和未来趋势

简介目录
Product Code: 91338

The Cryostat Microbiome Equipment Market is projected to register a CAGR of 6.89% during the forecast period (2022 to 2027).

The healthcare system has witnessed enormous challenges as a result of the COVID-19 pandemic. All outpatient treatments were postponed or restricted during the COVID-19 pandemic to ​reduce the risk of viral transmission as most chronic therapies were regarded as non-urgent. The cryostat microtome equipment is widely used in diagnostic and research laboratories for the study of histopathology of tissues. COVID-19 had severely impacted the research on chronic diseases such as cancer. An article titled "Impact of the COVID-19 Pandemic on Cancer Researchers: A Qualitative Study of Events to Inform Mitigation Strategies" published in the journal of Frontiers in Public Health in November 2021 discussed the impacts of the COVID-19 pandemic on cancer researchers. The article listed various factors such as financial resources, limited access to patients for research, decreased patient access to cancer care, staffing issues, administrative delays, or supply chain issues as the major limitations for the decline in the quantity of cancer research. Such a lack of trained personnel to handle cryostat microbiome equipment and disruptions in the supply chain is expected to have a significant impact on the growth of the market.

However, with the rise of the pandemic, increasing research in the immunohistochemistry of the COVID-19 infected tissues has positively impacted the growth of the cryostat microtome equipment market. For instance, an article presented in the Elsevier journal of Immunology in September 2021 titled "Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy" studied the efficacy of neutralizing antibodies for COVID-19 treatment implemented the use of cryo-immunohistology of organs for further studies. Such an increase in the use of cryostat microtome equipment is expected to boost the growth of the market during the forecast period.

Major chronic diseases such as cancer, cardiovascular diseases, chronic lung disease, stroke, Alzheimer's, diabetes, and chronic kidney disease are on the rise all over the world, which is adding to the growth of the cryostat microbiome equipment market.​ Cancer is a leading cause of death all around the world, accounting for around 10 million deaths in 2020. According to the GLOBOCAN 2020 report, the total number of people in the world affected by cancer in 2020 accounts for around 19,292,789 cases. The number is estimated to rise to 28,887,940 cases by 2040. ​According to the International Diabetes Federation Diabetes Atlas Tenth edition 2021, in 2021, around 537 million adults all over the world were found to have diabetes; with the numbers projected to grow to 643 million by 2030 and 783 million by 2045. The large population affected by chronic diseases and the increase in the necessity of cryostat microbiome equipment for the ease of diagnosis and treatment of such diseases is expected to propel the growth of the cryostat microbiome equipment market.​

Thus the above-mentioned factors are expected to drive the growth of the market during the forecast period.

Key Market Trends

The Diagnostic & Research Laboratories Segment is Expected to Hold a Major Market Share in the Cryostat Microbiome Equipment Market.

The diagnostic & research laboratories holds the major segment in the cryostat microbiome equipment market. The cryostat microbiome equipment holds an important part in the study of immunohistochemistry and histopathological studies of tissues, for example, biopsies. An article published in the journal of Proceedings of the National Academy of Sciences in December 2020 titled "Deep learning extended depth-of-field microscope for fast and slide-free histology" showed that cryostat microbiome are widely used methods for cutting thin sections of tissues in a short processing time period.

Another article titled "Histological-Based Stainings using Free-Floating Tissue Sections" published in the Journal of Visualized Experiments in August 2021 discussed the application of freefloating method to fluorescent immunohistochemistry staining. The article indicated that the cryostat microbiome equipment are the most preferrred method for slicing and collecting tissues for many researchers. The study aimed to reduce the processing time taken for staining the sliced frozen tissues. Such increase in research studies enabling the ease of use of the cryostat microbiome equipment are expected to propel the growth of the cryostat microbiome equipment market during the forecast period.

The increasing number of cancer cases and the associated treatments requiring the use of cryostat microbiome equipment for the disgnosis of the infected tissues are likely to drive the growth of the market. For example, an article titled "Diagnostic Biopsy via In-Office Frozen Sections for Clinical Nonmelanoma Skin Cancer" presented in the journal of Dermatologic Surgery in February 2021 focused on measuring the accuracy and outcomes of biopsy via frozen sections for clinical non melanoma skin cancer. The study indicated that the in-office biopsy via frozen sections were highly accurate in confirmation of the non melanoma skin cancer cells and that the practice might help in speeding up the diagnosis and treatment of the disease thereby enhancing outcomes and patient satisfaction. The increasing research on the study of diagnosis and treatment of cancer cases with the use of cryostat microbiome equipment is expected to boost the growth of the studied market over the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period (2022 - 2027).

The rise in the adoption of highly advanced techniques and systems in the manufacturing of cryostat microbiome equipments and the technological advancements made in immunohistochemistry studies is expected to boost the growth of the market in the North American region. The high awareness among the population on the availability of innovative cryostat microbiome equipment models in the market contributes to the high market growth in the region.

The rising number of chronic disease cases in the North American region is adding to the growth of the cryostat microbiome equipment market.​ Cancer is one of the top ten leading causes of death in the United States. According to the GLOBOCAN 2020 report, the total number of people in the United States affected by cancer in 2020 accounts to around 2,281,658 cases. The number is estimated to rise to 3,123,452 cases by 2040. ​According to the International Diabetes Federation, in 2021, total number of diabetes in adults in united States were 32,215,300 with a prevalence of over 13%. ​TheCenter for Disease Control and Prevention in 2021 reported that 37million United States Adults are estimated to have chronic kidney disease in 2021. The report by the Center for Disease prevention and Control in 2020 showed that around 15.7 million Americans are affected by chronic lower respiratory Disease.​ The large population affected by the chronic diseases and the increase in the necessity of cryostat microbiome equipment for the ease of diagnosis and treatment of such diseases is expected to propel the growth of the cryostat microbiome equipment market.​

Also, the increasing healthcare expenditure in the United States is expected to drive the demand for the cryostat microbiome equipment market in this region. According to the United States Centers for Medicare & Medicaid Services' National Health Expenditure Data 2020, the healthcare expenditure grew upto 9.7% to USD 4.1 trillion in 2020 and accounted for around 19.7% of the Gross Domestic Product. The expenditure is projected to reach USD 6.2 trillion by 2028. The rise in the healthcare expenditure in the United States region is likely to boost the growth of the cryostat microbiome equipment market over the forecast period of the study.

Thus the increasing necessity for cryostat microbiome equipment coupled with increasing investment in the health care department is known to propel the growth of the market in this region.

Competitive Landscape

The Cryostat Microbiome Equipment Market is fragmented competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Amos Scientific Pty. Ltd., Bright Instruments Ltd., Cardinal Health, Epredia, Hacker Instruments & Industries Inc., Histo-Line Laboratories S.R.L., Kalstein France, Labtron Equipment Ltd., Leica Microsystems Nussloch GmbH, Medimeas Instruments, Sakura Finetek Usa Inc., Slee Medical Gmbh, Spensers World, Tanner Scientific Inc., Zhejiang Jinhua Kedi Instrumental Equipment Co., Ltd. and others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and market definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Chronic Diseases
    • 4.2.2 Rising Healthcare Expenditure
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Professionals
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Manual Cryostat Microtome Equipment
    • 5.1.2 Semi-automatic Cryostat Microtome Equipment
    • 5.1.3 Automatic Microtome Cryostat Equipment
  • 5.2 End User
    • 5.2.1 Hospitals
    • 5.2.2 Ambulatory Surgical Centers
    • 5.2.3 Diagnostic & Research Laboratories
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.2 Europe
    • 5.3.3 Asia-Pacific
    • 5.3.4 Middle-East and Africa
    • 5.3.5 South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Amos Scientific Pty. Ltd.
    • 6.1.2 Bright Instruments Ltd.
    • 6.1.3 Cardinal Health
    • 6.1.4 Epredia
    • 6.1.5 Hacker Instruments & Industries Inc.
    • 6.1.6 Histo-Line Laboratories S.R.L.
    • 6.1.7 Kalstein France
    • 6.1.8 Labtron Equipment Ltd.
    • 6.1.9 Leica Microsystems Nussloch GmbH
    • 6.1.10 Medimeas Instruments
    • 6.1.11 Sakura Finetek Usa Inc.
    • 6.1.12 Slee Medical Gmbh
    • 6.1.13 Spensers World
    • 6.1.14 Tanner Scientific Inc.
    • 6.1.15 Zhejiang Jinhua Kedi Instrumental Equipment Co., Ltd.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS